SOHO regional meeting in Brazil delivers again
Heme professionals report high burnout in EHA member survey
Early data support glofitamab combo in high-risk LBCL
Dr. Masarova discusses SURPASS-ET study at EHA 2025
The journey of belantamab mafodotin in multiple myeloma

Join SOHO

Insider Podcast
About
Society Updates
- Society Updates
- Join SOHO
Resources
Hem/Onc Library
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Meeting News
Multimedia
- Roundtable Discussions
  - MDS Roundtable
  - MPN Roundtable
- Video Interviews
Subscribe

About Us

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

Join SOHO

Multiple Myeloma News

Multiple Myeloma

FDA accepts BLA review for Blenrep combo in relapsed or refractory MM

by SOHO Insider Editors
February 10, 2025
0 Comments

Multiple Myeloma

Real-world study finds this triplet therapy is an option for daratumumab-refractory myeloma

by SOHO Insider Editors
February 10, 2025
0 Comments

Chronic Lymphocytic Leukemia Lymphoma Indolent B-Cell Lymphomas Multiple Myeloma

Is a stronger flu vaccine better for blood cancer patients?

by Leah Sherwood
February 3, 2025
0 Comments

Multiple Myeloma News

CARTITUDE-4 findings show improved health-related quality of life with cilta-cel for multiple myeloma

by SOHO Insider Editors
January 27, 2025
0 Comments

Cellular Therapy Multiple Myeloma News

Do older patients with myeloma respond as well to ide-cel as younger patients?

by Leah Sherwood
January 14, 2025
0 Comments

Multiple Myeloma News Society Updates

Message from Editor-in-Chief Dr. Lonial: Advancing care amid uncertainty

by Leah Sherwood
January 13, 2025
0 Comments

Multiple Myeloma News

Introducing SOHO Insider

by Leah Sherwood
December 12, 2024
0 Comments

Multiple Myeloma

MRD2STOP trial supports discontinuation of maintenance therapy in MM patients with low MRD negativity

by Leah Sherwood
December 3, 2024
0 Comments

Multiple Myeloma

BVd Outperforms DVd in Phase III DREAMM 7 study

by sohonews
October 22, 2024
0 Comments

Multiple Myeloma

FDA approves daratumumab plus hyaluronidase – based quadruplet therapy

by sohonews
October 22, 2024
0 Comments

1
2
3
4

Top Categories

Cellular Therapy

12

Leukemia

43

Lymphoma

44

Multiple Myeloma

31

Myelodysplastic Syndromes

13

Myeloproliferative Neoplasms

10

POPULAR NEWS

Leukemia , Lymphoma , Multiple Myeloma , Myelodysplastic Syndromes , Myeloproliferative Neoplasms , News , Society Updates

Abstract submissions now open for SOHO 2025

February 14, 2025

66th American Society of Hematology Annual Meeting & Exposition , Leukemia

Asciminib benefit-risk profile bests other TKIs in CML

December 10, 2024

Leukemia , Acute Myeloid Leukemia , Myelodysplastic Syndromes

NCI’s myeloMATCH pushes the envelope in myeloid leukemia care

January 3, 2025

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

About Us

Categories

Cellular Therapy

Leukemia

Lymphoma

Multiple Myeloma

Myelodysplastic Syndromes

Myeloproliferative Neoplasms

Contact Info

Multiple Myeloma News

FDA accepts BLA review for Blenrep combo in relapsed or refractory MM

Real-world study finds this triplet therapy is an option for daratumumab-refractory myeloma

Is a stronger flu vaccine better for blood cancer patients?

CARTITUDE-4 findings show improved health-related quality of life with cilta-cel for multiple myeloma

Do older patients with myeloma respond as well to ide-cel as younger patients?

Message from Editor-in-Chief Dr. Lonial: Advancing care amid uncertainty

Introducing SOHO Insider

MRD2STOP trial supports discontinuation of maintenance therapy in MM patients with low MRD negativity

BVd Outperforms DVd in Phase III DREAMM 7 study

FDA approves daratumumab plus hyaluronidase – based quadruplet therapy

Categories

Cellular Therapy

Leukemia

Lymphoma

Multiple Myeloma

Myelodysplastic Syndromes

Myeloproliferative Neoplasms

Recent Posts

SOHO regional meeting in Brazil delivers again

Heme professionals report high burnout in EHA member survey

Early data support glofitamab combo in high-risk LBCL

About Us

Categories

Cellular Therapy

Leukemia

Lymphoma

Multiple Myeloma

Myelodysplastic Syndromes

Myeloproliferative Neoplasms

Contact Info

Follow Us

Multiple Myeloma News

Cellular Therapy

Leukemia

Lymphoma

Multiple Myeloma

Myelodysplastic Syndromes

Myeloproliferative Neoplasms